Welcome to our dedicated page for Cemtrex SEC filings (Ticker: CETX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cemtrex Inc. filings document a public operating company with Security, Industrial, and Aerospace & Defense activities, including governance matters, capital-structure transactions, acquisitions, and material agreements. Proxy filings cover shareholder voting and corporate governance, while current reports record completed business acquisitions, registered direct offerings, common stock and pre-funded warrant issuances, and Series 1 Preferred Stock dividend treatment.
The filing record also includes acquisition disclosures for Invocon and Richland Industries, including asset or share purchase agreements, completion reports, financing arrangements, and related financial statement or pro forma information. These documents describe how acquired operations are incorporated into Cemtrex’s industrial services and aerospace-defense platforms, alongside the company’s ongoing securities and reporting obligations.
Cemtrex, Inc., through its Advanced Industrial Services subsidiary, completed the acquisition of substantially all assets of Richland Industries in Tennessee and bought its main operating facility. AIS paid $600,000 for the business assets and $4,900,000 for the Pulaski facility.
The business asset purchase was financed with a Fulton Bank note at 6.09% interest maturing February 1, 2031. The real estate purchase was funded with a $3,920,000 Fulton Bank mortgage at SOFR plus 2.75% maturing February 1, 2041, plus cash for the remaining price and closing costs.
Richland’s operations are being integrated into Cemtrex’s Industrial Services segment via new subsidiary AIS Tennessee. Based on historical performance and current backlog, AIS Tennessee is expected to contribute approximately $8 to $10M in revenue over the next twelve months, expanding AIS’s presence in the Southeastern U.S.
Cemtrex, Inc. filed Amendment No. 1 to its annual report for the year ended September 30, 2025 to add Exhibit 97.1, the company’s Clawback Policy required under SEC Rule 10D-1. The amendment also includes new CEO and CFO certifications under Sections 302 of the Sarbanes-Oxley Act, with certain paragraphs omitted because no financial statements are included.
The company states that, aside from adding the clawback policy and updated certifications, no other parts of the original report are changed or updated. As context, common stock held by non-affiliates was 118,982 shares with an aggregate market value of $2,623,509 as of March 31, 2025, and 6,911,663 shares were outstanding as of December 22, 2025.
Cemtrex, Inc. is conducting a registered direct primary offering of up to $4,000,000 of common stock or pre-funded warrants to a single accredited institutional investor at $2.722 per share or $2.721 per pre-funded warrant. Assuming only shares are issued, this implies up to 1,469,507 shares or an equal number of warrant shares. As of January 8, 2026, Cemtrex had 8,600,552 common shares outstanding and a public float of about $60.6 million.
The company expects net proceeds of approximately $3,950,000, to be used for working capital and general corporate purposes, including potential future acquisitions. No underwriter or placement agent is involved. Investors face significant dilution, with an estimated dilution of about $2.05 per share based on recent share issuances.
Cemtrex reports large net losses of $28.1 million in 2025 and $7.2 million in 2024 and substantial near‑term debt, leading auditors to express substantial doubt about its ability to continue as a going concern. Recent actions include multiple reverse stock splits, several equity offerings, a $7,025,000 promissory note, and a $7,060,000 cash acquisition of aerospace firm Invocon, which forms a new Aerospace & Defense segment.
Cemtrex Inc. entered into a Securities Purchase Agreement on January 9, 2026 with a single accredited institutional investor for a registered direct offering of common stock and pre-funded warrants. The company agreed to issue and sell securities for aggregate gross proceeds of $4,000,000.
The offering closed the same day. Cemtrex issued 400,000 shares of common stock and pre-funded warrants to purchase 1,069,507 shares of common stock. The agreement includes customary representations, warranties, and covenants. Cemtrex also filed the form of pre-funded warrant, the purchase agreement, a legal opinion from The Doney Law Firm, and a press release announcing the offering as exhibits.
Cemtrex, Inc. has completed its previously announced acquisition of Invocon, Inc. On January 8, 2026, the company closed the share purchase agreement signed on November 13, 2025, buying 100% of Invocon’s outstanding shares for $7,060,000 in cash, paid at closing. Following the transaction, Invocon became a wholly-owned subsidiary of Cemtrex.
The filing notes that the detailed share purchase agreement was previously filed and that its representations and warranties primarily allocate risk between the parties. Cemtrex plans to file Invocon’s financial statements and required pro forma financial information by amendment within 71 calendar days of the required filing date. Cemtrex also issued a press release announcing the completion of the acquisition, furnished as Exhibit 99.1.
Cemtrex Inc. entered into a Securities Purchase Agreement with a single accredited institutional investor for a registered direct offering generating aggregate gross proceeds of $2,000,000. The transaction involved the sale of common equity and pre-funded warrants to that investor.
The offering closed on December 11, 2025, with Cemtrex issuing 310,000 shares of common stock and pre-funded warrants to purchase 356,667 additional shares of common stock. Legal counsel The Doney Law Firm delivered an opinion on the legality of the securities, and Cemtrex issued a press release describing the offering, which is included as an exhibit.
Cemtrex is conducting a registered direct offering of up to $2,000,000 of common stock or pre-funded warrants to a single accredited institutional investor. Shares are priced at $3.00, or $2.999 per pre-funded warrant with a $0.001 exercise price and a 4.99% beneficial ownership cap, for up to 666,667 shares or equivalent. There is no underwriter, and net proceeds are estimated at approximately $1,950,000.
The company plans to use the cash for working capital and general corporate purposes, including potential acquisitions. As of December 10, 2025, 6,217,047 shares of common stock were outstanding, and the stock trades on the Nasdaq Capital Market under the symbol CETX.
The filing also underscores elevated risk: Cemtrex reports recent operating losses, near-term debt obligations of $12,067,849 and working capital of $4,916,624, and its auditor’s report includes a going concern paragraph. Management highlights reliance on prior equity raises, a $7,025,000 secured convertible note issued in November 2025, and a 1-for-15 reverse stock split completed on September 29, 2025 to support liquidity and Nasdaq listing, while warning of potential further dilution and ongoing listing compliance challenges.
Cemtrex, Inc. entered into a Share Purchase Agreement to acquire 100% of the issued and outstanding shares of Invocon, Inc., a Texas-based systems‑engineering firm, for a purchase price of $7,060,000. The transaction is expected to close on or around January 1, 2026, and is contingent on customary closing conditions.
Invocon provides turnkey solutions for demanding applications in extreme environments across aerospace, defense, and civil structure monitoring, serving major corporations, government entities, and universities. After the acquisition is completed, Cemtrex plans to create a new reporting segment called Aerospace & Defense, signaling a formal expansion into this end market.
Cemtrex, Inc. entered a material definitive agreement, issuing a promissory note to Streeterville Capital, LLC with an original principal of $7,025,000. After $25,000 in original issuance fees, the company received $7,000,000 in cash.
Interest accrues at the daily SOFR rate from November 7, 2025 through December 31, 2025, then at 8% per annum beginning January 1, 2026. If the note remains outstanding on January 1, 2026, a one-time additional interest fee of $1,050,000 will be added to the balance. The note matures eighteen months from issuance, with redemptions starting six months after issuance. Cemtrex states it intends to use the cash proceeds to complete potential acquisitions.
Cemtrex Inc. is implementing a 1-for-15 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on September 29, 2025. The stock will begin trading on a split-adjusted basis that day under the same trading symbol, CETX, with a new CUSIP number 15130G873.
As of this filing, Cemtrex has 11,084,809 shares of common stock outstanding, which will be reduced to roughly one-fifteenth of that amount after the split, subject to rounding of fractional shares. The reverse split was approved earlier by stockholders and is intended to help the company regain compliance with Nasdaq’s minimum $1.00 bid price requirement.
Most options, warrants, and equity awards will be proportionately adjusted so that holders keep essentially the same aggregate exercise price. However, Cemtrex discloses that its Adjustable Warrants, currently exercisable for 15,412,956 shares at an exercise price of $0.5737 per share, contain provisions that will reduce the post-split exercise price and significantly increase the number of underlying shares, while keeping the total exercise price the same.